Dados B3 › CAML3 × ABEV3
CAML3 × ABEV3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | CAML3 | ABEV3 | year |
|---|---|---|---|
| ROE | 6.6% | 16.6% | 2025 |
| ROIC | 10.3%! | 26.6% | 2025 |
| ROA | 2.0% | 10.4% | 2025 |
| Gross margin | 19.5% | 51.4% | 2025 |
| EBIT margin | 5.2% | 26.5% | 2025 |
| Net margin | 1.8% | 18.1% | 2025 |
| Net debt/EBITDA | 3.29x | -0.56x | 2025 |
| Current ratio | 1.64x | 0.96x | 2025 |
| Revenue growth (1y) | 9.0% | -1.4% | 2025 |
| Revenue growth (5y CAGR) | 17.8% | 8.6% | 2025 |
| Piotroski F-Score | 6/9 | 6/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | CAML3 | ABEV3 | year |
|---|---|---|---|
| P/E | 14.53x | 16.64x | 2026 × 2025 |
| P/B | 0.71x | 2.93x | 2026 × 2025 |
| EV/EBITDA | 5.90x | 7.97x | 2026 × 2025 |
| FCF yield | 1.3% | 7.7% | 2026 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:26 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:26 UTC. If this does not match /saude, you are reading a cached copy.